Shionogi & Co Ltd ADR (SGIOY PINK) stock market data APIs
$9.2792
0.22(2.4%)
as of January 9, 2026
Try our APIs with
free plan!
Shionogi & Co Ltd ADR Financial Data Overview
Price chart is built with
Anychart
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Osaka, Japan.
Prev. Close
9.2792
Open
9.503
High
9.5714
Low
9.2614
52 wk Range
6.6396-9.58
Market Cap
15 838 M
P/E Ratio
14.4531
Shares Outstanding
1 702 M
Revenue
437 263 M
EPS
0.176
Dividends (Yield)
0.0237
Beta
-0.081
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Shionogi & Co Ltd ADR (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Shionogi & Co Ltd ADR data using free add-ons & libraries
Get Shionogi & Co Ltd ADR Fundamental Data
Shionogi & Co Ltd ADR Fundamental data includes:
- Net Revenue: 437 263 M
- EBITDA: 179 035 M
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-27
- EPS/Forecast: 0.1712
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Shionogi & Co Ltd ADR News
New
Shionogi (TSE:4507): Evaluating Valuation After a Strong Year-to-Date Share Price Gain
Shionogi (TSE:4507) has quietly delivered a strong year-to-date run, and that kind of move usually prompts a simple question for investors: is this still an opportunity or has the easy money already b...
Tanabe Pharma America Announces Transfer of RADICAVA® Business to Shionogi
U.S. and Canada transaction supports continued access to RADICAVA® for people living with ALS while enabling Tanabe Pharma America to focus on future growth and innovation JERSEY CITY, N.J., Dec. 22...
Shionogi Expands Rare Disease Presence with Planned Acquisition of Global Rights to Tanabe Pharma Corporation’s RADICAVA ORS® (edaravone) and IV RADICAVA
Shionogi to purchase the rights and assets of the global RADICAVA business establishing a strong commercial platform in rare disease to support future launches As part of the transaction, a new busine...
BioVersys Announces BV100 Phase 3 Initiation and Provides a Business Update
BioVersys Ad hoc announcement pursuant to Art. 53LR BASEL, Switzerland, Dec. 11, 2025 (GLOBE NEWSWIRE) -- BV100 Phase 3 in Ventilator Associated Bacterial Pneumonia initiated with first country sub...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
